Canaccord Genuity

Canaccord Genuity's surveys are pointing to soft smartphone demand, including for tech giant Apple Inc. (NASDAQ: AAPL)'s iPhone.  The Analyst Analyst T. Michael Walkley reiterated a Buy rating on Apple and lowered the price target from $250 to $225. The Thesis Canaccord's...

Foot Locker, Inc. (NASDAQ: FL) shares are soaring after the retailer reported a third-quarter earnings and sales beat Tuesday. The footwear retailer reported Q3 earnings of 95 cents per share, beating estimates by 3 cents. Sales came in at $1.86 billion, beating estimates by $10 million. Many...

Autodesk, Inc. (NASDAQ: ADSK) stock is trading higher by 8 percent after the company reported better-than-expected third-quarter earnings and issued fourth-quarter guidance ahead of Wall Street estimates. Autodesk reported adjusted Q3 EPS of 29 cents on revenue of $660.9 million. Analysts has...

Canada-based BlackBerry Ltd (NYSE: BB) reached an agreement last week to acquire Cylance, a threat detection cybersecurity company with a specialty in artificial intelligence. Here's how the sell-side reacted to BlackBerry's largest M&A move to date.   The Analysts CIBC...

A Canaccord Genuity analyst came away from a meeting with Mallinckrodt PLC (NYSE: MNK)'s executive team with an upbeat forecast for the pharma company's near-term prospects.  The Analyst Analyst Dewey Steadman upgraded Mallinckrodt from Hold to Buy and increased the price target...

Blue Apron Holdings Inc (NYSE: APRN) shares are reeling after reporting a third-quarter earnings miss Tuesday. The food delivery subscription service has lost nearly 88 percent of its value since its 2017 IPO.  The Analyst  Canaccord Genuity analyst Michael Graham downgraded Blue...

Apple Inc. (NASDAQ: AAPL)'s stock has entered bear market territory, with the performance of its newest iPhone models largely to blame.  The stock has pulled back by about 20 percent from an Oct. 3 intraday high of $233.47.  Apple shares have underperformed since October, having shed...

Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) have dropped by about 12 percent since the company reported third-quarter results Nov. 8. Analysts at HC Wainwright and Canaccord Genuity consider the sell-off an overreaction and issued positive updates on the company this week.  The Analysts HC...

MedMen Enterprises Inc. (OTC: MMNFF), one of the largest marijuana dispensary operators in the United States, plans to raise CAD 120 million ($91 million) after it entered into a letter of engagement with financial services company Canaccord Genuity. What Happened In a press release, MedMen...

Chipmaker Qualcomm, Inc. (NASDAQ: QCOM) reported Wednesday with fiscal fourth-quarter results that arrived better than expected, but the Q1 guidance disappointed. Here's how three Street analysts covering the stock reacted. The Analyst Canaccord Genuity's T. Michael Walkley...